PRP Spinoplasty for Chronic Low Back Pain With Multiple Pathologies: A Quasi-Experimental Study

NCT ID: NCT07268885

Last Updated: 2025-12-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

35 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-15

Study Completion Date

2025-09-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This study aimed to evaluate the efficacy and safety of a comprehensive, multi-target injection protocol, termed 'PRP Spinoplasty,' for managing chronic LBP stemming from concurrent lumbar disc and facet joint disease with associated muscle spasms.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A quasi-experimental study was conducted on 29 patients with chronic LBP who failed conservative therapy. The PRP Spinoplasty protocol involved a single-session, fluoroscopy-guided administration of autologous PRP to the interlaminar epidural space, affected facet joints, and paraspinal muscle trigger points. Outcomes were assessed using the Numeric Pain Scale (NPS), Oswestry Disability Index (ODI), and Single Assessment Numeric Evaluation (SANE) at baseline and at 1 week, 1 month, 3 months, and 6 months post-procedure.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lower Back Pain Chronic Lumbar Disc Disease Facet Joint Arthritis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Adult patients with chronic low back pain secondary to lumbar disc disease and facet arthropathy

The study population consisted of 35 adult patients with a diagnosis of chronic low back pain secondary to lumbar disc disease and facet arthropathy, with an associated component of muscular spasm. Diagnoses were confirmed by an interventional pain specialist based on a detailed medical history, physical examination, and magnetic resonance imaging (MRI) findings.

Group Type EXPERIMENTAL

Spinoplasty with Platelet Rich Plasma

Intervention Type BIOLOGICAL

The patient received a procedure called "Spinoplasty" which interlaminar epidural, facet joints and trigger point injection with Platelet Rich Plasma (PRP).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Spinoplasty with Platelet Rich Plasma

The patient received a procedure called "Spinoplasty" which interlaminar epidural, facet joints and trigger point injection with Platelet Rich Plasma (PRP).

Intervention Type BIOLOGICAL

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

Epidural injection Facet Joint Injection Trigger Point Injection

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Individuals of both sexes; ages between 18 and 80 years.
* Lower back pain consistent with lumbosacral radiculopathy, facet arthropathy, and muscle spasms.
* MRI-confirmed lumbar spine pathology (disc disease and/or facet arthropathy).
* Failure to respond to at least 3 months of conservative therapy (NSAIDS and physical therapy).
* Pain score ≥ 6; on the 10-point Numeric Pain Scale (NPS) at baseline.

Exclusion Criteria

* Presence of local or systemic infection, or fever.
* Diagnosed with cancer within the past 12 months.
* Unable to give a consent.
* History of spinal deformity such as fracture, or severe spinal stenosis causing neurological deficit.
* Presence of lower extremity weakness or urinary tract symptoms related to spinal pathology.
* Previous spinal decompression or fusion surgery at the treatment level.
* Receipt of any spine injection within the previous 12 months.
* Use of NSAIDs within 2 weeks prior to, or 6 weeks following the procedure.
* Use of corticosteroids within 6 weeks prior, or after the procedure.
* Use of anticoagulation or antiplatelet drugs (excluding low-dose Aspirin).
* History of blood disorders.
* History of any major surgery within the past 3 months.
Minimum Eligible Age

18 Years

Maximum Eligible Age

80 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Allmed Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Dr. Mustafa A Hammad

Medical Director and Principal Investigator

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Mustafa A Hammad, MD

Role: PRINCIPAL_INVESTIGATOR

Allmed Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Allmed Medical Center

Ramallah, , Palestinian Territories

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Palestinian Territories

Related Links

Access external resources that provide additional context or updates about the study.

https://pubmed.ncbi.nlm.nih.gov/34907784/

Machado ES, Ambach MA, Caldas JM, Wei JJ, Bredemeier M. Personalized multitarget biologic injection in the spine: prospective case series of multitarget platelet-rich plasma for low back pain. Regen Med. 2022;17(1):11-22

http://doi.org/10.2147/JPR.S444189

Zhang X et al. The Clinical Efficacy of Platelet-Rich Plasma Injection Therapy versus Different Control Groups for Chronic Low Back Pain: A Network Meta-Analysis of Randomized Controlled Trials. J Pain Res. 2024;17:1077-1089

http://doi.org/10.3389/ebm.2025.10390

Muthu S, Viswanathan VK, Gangadaran P. Is platelet-rich plasma better than steroids as epidural drug of choice in lumbar disc disease with radiculopathy? Meta-analysis of randomized controlled trials. Exp Biol Med. 2025;Volume 250

http://doi.org/10.21037/jss.2018.03.04

Mohammed S, Yu J. Platelet-rich plasma injections: an emerging therapy for chronic discogenic low back pain. J Spine Surg. 2018;4(1):115

http://pubmed.ncbi.nlm.nih.gov/40823278/

Baltzer AW, Enneper J, Baltzer LM, Godde G. Platelet Rich Plasma for the Therapy of the Lumbar Facet Joint Syndrome: A Prospective Study About CT-Guided Facet Joint Injections With PRP Compared to Local Anesthetics. Orthop Rev (Pavia). 2025;17:141416

http://doi.org/10.1055/S-0040-1709170

Xuan Z, Yu W, Dou Y, Wang T. Efficacy of Platelet-rich Plasma for Low Back Pain: A Systematic Review and Meta-analysis. J Neurol Surgery, Part A Cent Eur Neurosurg. 2020;81(6):529-534

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

HC.MRC.March4222024

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Intra-discal Injection of PRP for Low Back Pain
NCT03712527 ACTIVE_NOT_RECRUITING NA
Spinal Cord Stimulation for Low Back Pain
NCT00205868 COMPLETED PHASE4